Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Inventiva S.A. | IVA | $4.78 | $1.13B | — | |
| Savara Inc. | SVRA | $5.37 | $1.10B | — | |
| Solid Biosciences Inc. | SLDB | $10.25 | $1.10B | — | |
| WELL Health Technologies Corp. | WELL.TO | CA$4.25 | CA$1.09B | 212.5 | — |
| Enovis Corporation | ENOV | $18.56 | $1.07B | — | |
| IRADIMED CORPORATION | IRMD | $83.45 | $1.07B | 46.6 | 0.92% |
| Pacira BioSciences, Inc. | PCRX | $26.35 | $1.05B | 75.3 | — |
| CureVac N.V. | CVAC | $4.66 Jan 6, 2026 | $1.05B | 7.0 | — |
| Obsidian Therapeutics, Inc. | OBX | $16.82 | $1.04B | — | |
| Faeth Therapeutics, Inc. | FTH | $40.05 | $1.03B | — | |
| Avalo Therapeutics, Inc. | AVTX | $19.23 | $1.03B | — | |
| Arbutus Biopharma Corporation | ABUS | $5.15 | $1.02B | 6.5 | — |
| Geron Corporation | GERN | $1.57 | $1.01B | — | |
| Castle Biosciences, Inc. | CSTL | $32.91 | $1.01B | — | |
| Ventyx Biosciences Inc | VTYX | $14.00 Mar 6, 2026 | $1.00B | — | |
| Lexicon Pharmaceuticals, Inc. | LXRX | $2.24 | $996.70M | — | |
| Immix Biopharma, Inc. | IMMX | $13.91 | $990.25M | — | |
| Amphastar Pharmaceuticals, Inc. | AMPH | $23.18 | $986.03M | 13.7 | — |
| Knight Therapeutics Inc. | GUD.TO | CA$10.01 | CA$983.30M | 66.7 | — |
| Candel Therapeutics, Inc. | CADL | $12.78 | $977.91M | — | |
| Ardelyx, Inc. | ARDX | $3.78 | $975.95M | — | |
| SpyGlass Pharma, Inc. | SGP | $28.94 | $967.98M | — | |
| Adlai Nortye Group Ltd. | ANL | $15.01 | $966.61M | — | |
| Bioventus Inc. | BVS | $14.07 | $961.05M | 18.5 | — |
| QuidelOrtho Corporation | QDEL | $13.97 | $958.00M | — | |
| Wave Life Sciences, Inc. | WVE | $4.86 | $957.65M | — | |
| CeriBell, Inc. | CBLL | $24.72 | $948.71M | — | |
| Design Therapeutics, Inc. | DSGN | $15.14 | $947.49M | — | |
| Olema Pharmaceuticals, Inc. | OLMA | $10.75 | $940.60M | — | |
| Annexon, Inc. | ANNX | $4.87 | $923.25M | — | |
| Rigel Pharmaceuticals, Inc. | RIGL | $48.67 | $909.15M | 2.9 | — |
| Aclaris Therapeutics, Inc. | ACRS | $6.17 | $908.22M | — | |
| Silence Therapeutics plc | SLN | $14.59 | $906.83M | — | |
| Cybin D/B/A Helus Pharma | HELP | $12.22 | $892.80M | — | |
| Climb Bio, Inc. | CLYM | $15.52 | $891.41M | — | |
| Theravance Biopharma, Inc. | TBPH | $17.08 | $886.77M | 16.4 | — |
| Anteris Technologies Global Corp. | AVR | $9.04 | $881.02M | — | |
| Beta Bionics, Inc. | BBNX | $19.42 | $873.70M | — | |
| Achieve Life Sciences, Inc. | ACHV | $8.49 | $873.64M | — | |
| Talkspace Inc | TALK | $5.25 Aug 18, 2026 | $870.57M | — | |
| AdaptHealth Corp. | AHCO | $6.49 | $865.83M | — | |
| InMode Ltd. | INMD | $14.91 | $857.98M | 12.3 | — |
| HealthStream, Inc. | HSTM | $29.20 | $853.81M | 41.1 | 0.46% |
| DBV Technologies S.A. | DBVT | $13.47 | $846.53M | — | |
| Glass House Brands Inc. | GLAS | $8.88 | $836.87M | — | |
| SI-BONE, Inc. | SIBN | $18.50 | $829.14M | — | |
| 4D Molecular Therapeutics, Inc. | FDMT | $14.97 | $827.01M | — | |
| CytomX Therapeutics, Inc. | CTMX | $3.71 | $808.41M | — | |
| Esperion Therapeutics, Inc. | ESPR | $3.18 Jul 13, 2026 | $803.19M | — | — |
| ProKidney Corp. | PROK | $2.01 | $802.36M | — |
Inventiva S.A.
Healthcare / Biotechnology
- Market Cap
- $1.13B
- P/E
- unprofitable
Savara Inc.
Healthcare / Biotechnology
- Market Cap
- $1.10B
- P/E
- unprofitable
Solid Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $1.10B
- P/E
- unprofitable
WELL Health Technologies Corp.
Healthcare / Medical Care Facilities
- Market Cap
- CA$1.09B
- P/E
- 212.5
Enovis Corporation
Healthcare / Medical Devices
- Market Cap
- $1.07B
- P/E
- unprofitable
IRADIMED CORPORATION
Healthcare / Medical Devices
- Market Cap
- $1.07B
- P/E
- 46.6
- Dividend Yield
- 0.92%
Pacira BioSciences, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.05B
- P/E
- 75.3
CureVac N.V.
Healthcare / Biotechnology
- Market Cap
- $1.05B
- P/E
- 7.0
Obsidian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.04B
- P/E
- unprofitable
Faeth Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.03B
- P/E
- unprofitable
Avalo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.03B
- P/E
- unprofitable
Arbutus Biopharma Corporation
Healthcare / Biotechnology
- Market Cap
- $1.02B
- P/E
- 6.5
Geron Corporation
Healthcare / Biotechnology
- Market Cap
- $1.01B
- P/E
- unprofitable
Castle Biosciences, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.01B
- P/E
- unprofitable
Ventyx Biosciences Inc
Healthcare / Biotechnology
- Market Cap
- $1.00B
- P/E
- unprofitable
Lexicon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $996.70M
- P/E
- unprofitable
Immix Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $990.25M
- P/E
- unprofitable
Amphastar Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $986.03M
- P/E
- 13.7
Knight Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$983.30M
- P/E
- 66.7
Candel Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $977.91M
- P/E
- unprofitable
Ardelyx, Inc.
Healthcare / Biotechnology
- Market Cap
- $975.95M
- P/E
- unprofitable
SpyGlass Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $967.98M
- P/E
- unprofitable
Adlai Nortye Group Ltd.
Healthcare / Biotechnology
- Market Cap
- $966.61M
- P/E
- unprofitable
Bioventus Inc.
Healthcare / Medical Devices
- Market Cap
- $961.05M
- P/E
- 18.5
QuidelOrtho Corporation
Healthcare / Medical Devices
- Market Cap
- $958.00M
- P/E
- unprofitable
Wave Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $957.65M
- P/E
- unprofitable
CeriBell, Inc.
Healthcare / Medical Devices
- Market Cap
- $948.71M
- P/E
- unprofitable
Design Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $947.49M
- P/E
- unprofitable
Olema Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $940.60M
- P/E
- unprofitable
Annexon, Inc.
Healthcare / Biotechnology
- Market Cap
- $923.25M
- P/E
- unprofitable
Rigel Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $909.15M
- P/E
- 2.9
Aclaris Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $908.22M
- P/E
- unprofitable
Silence Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $906.83M
- P/E
- unprofitable
Cybin D/B/A Helus Pharma
Healthcare / Biotechnology
- Market Cap
- $892.80M
- P/E
- unprofitable
Climb Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $891.41M
- P/E
- unprofitable
Theravance Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $886.77M
- P/E
- 16.4
Anteris Technologies Global Corp.
Healthcare / Medical Devices
- Market Cap
- $881.02M
- P/E
- unprofitable
Beta Bionics, Inc.
Healthcare / Medical Devices
- Market Cap
- $873.70M
- P/E
- unprofitable
Achieve Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $873.64M
- P/E
- unprofitable
Talkspace Inc
Healthcare / Health Information Services
- Market Cap
- $870.57M
- P/E
- unprofitable
AdaptHealth Corp.
Healthcare / Medical Devices
- Market Cap
- $865.83M
- P/E
- unprofitable
InMode Ltd.
Healthcare / Medical Devices
- Market Cap
- $857.98M
- P/E
- 12.3
HealthStream, Inc.
Healthcare / Health Information Services
- Market Cap
- $853.81M
- P/E
- 41.1
- Dividend Yield
- 0.46%
DBV Technologies S.A.
Healthcare / Biotechnology
- Market Cap
- $846.53M
- P/E
- unprofitable
Glass House Brands Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $836.87M
- P/E
- unprofitable
SI-BONE, Inc.
Healthcare / Medical Devices
- Market Cap
- $829.14M
- P/E
- unprofitable
4D Molecular Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $827.01M
- P/E
- unprofitable
CytomX Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $808.41M
- P/E
- unprofitable
Esperion Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $803.19M
ProKidney Corp.
Healthcare / Biotechnology
- Market Cap
- $802.36M
- P/E
- unprofitable
Showing 401–450 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.